Connection

Miguel Hernán to Risk Factors

This is a "connection" page, showing publications Miguel Hernán has written about Risk Factors.
Connection Strength

0.036
  1. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med. 2021 09 16; 385(12):1078-1090.
    View in: PubMed
    Score: 0.007
  2. ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19. J Clin Epidemiol. 2021 11; 139:240-254.
    View in: PubMed
    Score: 0.007
  3. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020 11 01; 180(11):1436-1447.
    View in: PubMed
    Score: 0.007
  4. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020 08 22; 396(10250):535-544.
    View in: PubMed
    Score: 0.007
  5. The Effect of the Opioid Epidemic on Donation After Circulatory Death Transplantation Outcomes. Transplantation. 2019 05; 103(5):973-979.
    View in: PubMed
    Score: 0.006
  6. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol. 2003 Aug; 60(8):1059-64.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.